Last Funding Type: Post-IPO Debt
Funding Status: IPO
Headquarters: Berkeley, California, United States
Founded Date: 1996-01-01
Last Funding Date: 2021-05-11
Total Funding: 1044500000
Employee Number: 501-1000
Estimated Revenue: $10M to $50M
Investors Number: 21
Industry: Tumor-Specific Antigens